在维替波芬有限供应时期，中枢性浆液性脉络膜视网膜病变推荐的半剂量光动力疗法。

IF 2.1 4区医学 Q2 OPHTHALMOLOGY

Ophthalmologica Pub Date : 2023-01-01 DOI:10.1159/000528923

Kah Long Aw, Wesley McLoughlin, Peter Cackett

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Half-Dose Photodynamic Therapy Recommended in the Management of Central Serous Chorioretinopathy during an Era of Limited Supplies of Verteporfin.

This is a letter submission. An abstract is normally not needed.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Ophthalmologica 医学-眼科学

CiteScore

5.10

自引率

3.80%

发文量

审稿时长

3 months

期刊介绍： Published since 1899, ''Ophthalmologica'' has become a frequently cited guide to international work in clinical and experimental ophthalmology. It contains a selection of patient-oriented contributions covering the etiology of eye diseases, diagnostic techniques, and advances in medical and surgical treatment. Straightforward, factual reporting provides both interesting and useful reading. In addition to original papers, ''Ophthalmologica'' features regularly timely reviews in an effort to keep the reader well informed and updated. The large international circulation of this journal reflects its importance.